ClinicalTrials.Veeva

Menu

Polyurethane Foam on the Sacrum for Prevention

I

Istituto Ortopedico Rizzoli

Status

Completed

Conditions

Hip Fracture
Pressure Ulcer

Treatments

Procedure: standard care
Device: hydrocellular polyurethane foam multilayer dressing

Study type

Interventional

Funder types

Other

Identifiers

NCT02692482
22022016

Details and patient eligibility

About

The aim of the present study is to assess whether the application of a new hydrocellular polyurethane foam multilayer dressing shaped for the sacral area (MSP) in addition to standard care reduces the rate of pressure sores (PU) and their severity especially in the elderly population admitted for fragility Hip Fractures.

Enrollment

359 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients aged ≥ 65 years with Hip fragility fracture without National Pressure Ulcers Advisory Panel scale (NPUAP) scale grade ≥ II PU
  • Patients or legal guardians who give their consent to take part in the study

Exclusion Criteria

  • Patients with known allergy to the product being tested or dermatological diseases that prevent the use of topical products
  • Patients with peri-prosthetic or pathological fractures
  • Patients with diaphyseal or distal femoral fractures

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

359 participants in 2 patient groups

polyurethane foam
Experimental group
Description:
Hydrocellular polyurethane foam multilayer dressing shaped for the sacral area
Treatment:
Device: hydrocellular polyurethane foam multilayer dressing
Procedure: standard care
standard care
Active Comparator group
Treatment:
Procedure: standard care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems